Being active reduces risk of prostate cancer
Important new findings relate to overall physical activity, not just intense exercise
5 December 2019
Prostate cancer is the most common cancer in men in the UK1 yet we still don’t know all of its causes. The largest ever study to use genetics as a measurement for physical activity to look at its effect on prostate cancer reveals that being more active reduces the risk of prostate cancer. Over 140,000 men were included in the study, of which, 80,000 had prostate cancer.
This new study, published in the International Journal of Epidemiology today2, was led by the University of Bristol and co-funded by World Cancer Research Fund (WCRF) and Cancer Research UK (CRUK). It found that people with the variation in their DNA sequence that makes them more likely to be active had a 51 per cent reduced risk of prostate cancer than people who did not have this particular variation. Importantly, the findings relate to overall physical activity, not just intense exercise.
WCRF’s own evidence has already shown that being active can reduce the risk of bowel, breast and womb cancer, but the evidence of physical activity on prostate cancer was limited. But this large study, which uses genetics as a proxy measurement for physical activity, shows that being active may in fact have a large impact on prostate cancer risk. To date there has been little evidence of ways to reduce prostate cancer risk other than maintaining a healthy weight.
Dr Sarah Lewis, Senior Lecturer in Genetic Epidemiology at Bristol Medical School: Population Health Sciences, and lead author of the research, said: "This study is the largest ever of its kind which uses a relatively new method that complements current observational research to discover what causes prostate cancer. It suggests that there could be a larger effect of physical activity on prostate cancer than previously thought, so will hopefully encourage men to be more active."
Dr Anna Diaz Font, Head of Research Funding at WCRF, said: “Up till now, there has only been limited evidence of an effect of physical activity on prostate cancer. This new study looked at the effect of 22 risk factors on prostate cancer, but the results for physical activity were the most striking. This will pave the way for even more research, where similar methods could be applied to other lifestyle factors, to help identify ways men can reduce their risk of prostate cancer.”
This new type of study, which combines genetics, lifestyle and cancer risk, supports previous evidence from observational studies that being active can reduce the risk of cancer.
For more information and media enquiries contact Maxine Lenza, Press and Communications Officer at WCRF on 020 7343 4235 or email@example.com
Notes to editors
Information on Mendelian Randomisation
A method of using variation in genes of known function between people to examine the causal effect of a modifiable exposure (ie diet) on disease (ie cancer) in observational studies. The use of genetics takes away any potential measurement, or human, error associated with questionnaires and participant recall which are often used to record lifestyle factors such as level of physical activity.
About World Cancer Research Fund
World Cancer Research Fund is part of a network of cancer charities with a global reach, dedicated to the prevention of cancer and survival through a healthy diet, maintaining a healthy weight, and being more physically active. We cut through the jargon to turn the latest global research on cancer prevention and survival into practical, straightforward advice and information, helping anyone who wants to reduce their risk of developing cancer to make fully informed lifestyle choices.
1Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424. https://doi.org/10.3322/caac.21492 PMID:30207593
2Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian randomisation study based on 79,148 prostate cancer cases and 61,106 controls by Kazmi et al in International Journal of Epidemiology.